The UAE respiratory care devices market size reached USD 243.80 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 516.53 Million by 2033, exhibiting a growth rate (CAGR) of 8.10% during 2025-2033. The UAE respiratory care devices market share is experiencing significant growth, driven by rising cases of respiratory diseases, increasing adoption of advanced healthcare technologies, government initiatives for improved patient care, expanding telemedicine solutions, and a growing demand for non-invasive ventilation, homecare devices, and remote patient monitoring systems.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 243.80 Million |
Market Forecast in 2033 | USD 516.53 Million |
Market Growth Rate (2025-2033) | 8.10% |
Growing Adoption of Homecare Respiratory Devices
The UAE respiratory care devices market growth is driven by an increase in home-based solutions, due to the rising cases of respiratory illnesses such as COPD and sleep apnea. For instance, as per the reports, doctors in the United Arab Emirates observed a notable increase in respiratory problems and attributed it to climatic changes where hot, dusty air mixes with high humidity, with temperatures topping 50°C and humidity levels hitting 100%. Clinics have shown that chest infections, including bronchitis, account for about half of daily cases. Patients prefer portable and user-friendly devices, including home ventilators, nebulizers, and CPAP machines. Advancements in telemedicine and remote monitoring further support this trend. The aging population and a rise in lifestyle-related respiratory conditions contribute to market growth. Manufacturers are focusing on compact, cost-effective, and AI-integrated devices to enhance home-based respiratory care.
Rising Demand for Smart and Connected Respiratory Devices
Technological advancements are revolutionizing respiratory care in the UAE, with smart and connected devices gaining popularity. The integration of IoT and AI allows real-time monitoring of patient conditions, improving treatment efficiency. Smart inhalers, wearable oxygen therapy devices, and Bluetooth-enabled spirometers enhance patient compliance. Hospitals and healthcare providers are increasingly adopting cloud-based data solutions for remote diagnosis and monitoring. For instance, on February 10, 2025, Burjeel Holdings unveiled one of the biggest Oracle Health Electronic Medical Record (EMR) platforms in the area, with the goal of revolutionizing patient care, improving clinical results, and increasing network operating efficiency. More than 3,700 workers are undergoing extensive training as part of this program, which is the biggest technology overhaul in Burjeel's history. The platform facilitates real-time coordination and information sharing between clinicians, patients, and facilities while promoting interoperability within Burjeel's clinical ecosystem. This trend is fueled by government initiatives supporting digital healthcare transformation and improving respiratory disease management, which in turn is positively impacting the UAE respiratory care market outlook.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on product, indication, and end-user.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product insight. This includes therapeutic devices (positive airway pressure (PAP) devices, ventilators, nebulizers, humidifiers, inhalers, and others), monitoring devices (pulse oximeters, gas analyzers, and others), diagnostic devices (spirometers, polysomnography devices, peak flow meters, and others), and consumables and accessories (masks, disposable resuscitators, breathing circuits, tracheostomy tubes, nasal cannulas, and others).
Indication Insights:
A detailed breakup and analysis of the market based on the indication insights have also been provided in the report. This includes chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious disease and others.
End-User Insights:
A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes hospitals, home care settings, ambulatory care centers, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Dubai, Abu Dhabi, Sharjah, and others.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered |
|
Indications Covered | Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Infectious Disease, Others |
End-Users Covered | Hospitals, Home Care Settings, Ambulatory Care Centers, Others |
Regions Covered | Dubai, Abu Dhabi, Sharjah, Others |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: